Can Motrin (ibuprofen) cause elevated liver enzymes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Motrin (Ibuprofen) Cause Elevated Liver Enzymes?

Yes, Motrin (ibuprofen) can cause elevated liver enzymes, with borderline elevations occurring in up to 15% of patients taking NSAIDs, and notable elevations (approximately three times the upper limit of normal) reported in about 1% of patients. 1

Liver Effects of Ibuprofen

Frequency and Severity

  • Borderline elevations of liver enzymes may occur in up to 15% of patients taking NSAIDs, including ibuprofen 1
  • Notable elevations of ALT or AST (approximately three or more times the upper limit of normal) have been reported in approximately 1% of patients in clinical trials with NSAIDs 1
  • Rare cases of severe hepatic reactions, including jaundice, fulminant hepatitis, liver necrosis, and hepatic failure (some with fatal outcomes) have been reported 1

Patterns of Liver Injury

  • Hepatocellular injury is the most common pattern seen with ibuprofen-induced liver injury 2
  • The liver enzyme abnormalities may:
    • Progress to more severe injury
    • Remain unchanged
    • Be transient with continuing therapy 1

Risk Factors and Considerations

Patient-Specific Risk Factors

  • Female gender appears to have higher risk for NSAID-induced liver injury, with one case-control study showing a significant association between liver injury and NSAID exposure in women [OR = 6.49 (1.67-25.16)] but not in men [OR = 1.06 (0.36-3.12)] 3
  • Pre-existing liver disease may increase risk, as patients with liver cirrhosis have impaired elimination of ibuprofen with prolonged half-life 4
  • Concomitant use of other hepatotoxic medications increases risk 5

Monitoring Recommendations

  • Patients on long-term treatment with NSAIDs should have their CBC and chemistry profile checked periodically 1
  • If clinical signs and symptoms consistent with liver disease develop, or if systemic manifestations occur (e.g., eosinophilia, rash), ibuprofen should be discontinued 1
  • For abnormal liver tests:
    • If liver enzymes are persistently elevated or worsen, ibuprofen should be discontinued 1
    • For elevations >5× ULN, discontinue medication and consider hepatology consultation 5

Clinical Presentation and Course

Warning Signs and Symptoms

Patients should be monitored for warning signs of hepatotoxicity, including:

  • Nausea
  • Fatigue
  • Lethargy
  • Pruritus
  • Jaundice
  • Right upper quadrant tenderness
  • "Flu-like" symptoms 1

Recovery Timeline

  • Full recovery typically occurs in most patients after discontinuation
  • In published cases, recovery took a mean time of 14 weeks 2
  • However, severe cases can progress to acute liver failure leading to death or liver transplantation 2

Clinical Approach to Suspected Ibuprofen-Induced Liver Injury

  1. Assess liver enzyme elevations:

    • <2× ULN: Continue medication with repeat testing in 2-4 weeks
    • 2-3× ULN: Consider dose reduction with close monitoring
    • 3-5× ULN: Consider temporary discontinuation or dose reduction with increased monitoring
    • 5× ULN: Discontinue medication and consider hepatology consultation 5

  2. Evaluate for other causes:

    • Consider other medications, alcohol consumption, viral hepatitis, and other liver diseases
    • Remember that NSAIDs are often used with other medications that may be hepatotoxic 5
  3. After discontinuation:

    • Monitor liver enzymes until normalization
    • If liver enzymes remain elevated after discontinuation, consider other diagnostic procedures 5

Despite these potential risks, ibuprofen is considered one of the safest NSAIDs with a very low prevalence of idiosyncratic hepatotoxicity 2. The absolute risk of severe ibuprofen-induced liver complications appears to be low, making it generally regarded as an efficacious and safe NSAID when used appropriately.

References

Research

Systematic review: ibuprofen-induced liver injury.

Alimentary pharmacology & therapeutics, 2020

Guideline

Medication-Induced Liver Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.